North Korean Defectors Reveal How Migration Reshapes Cancer Risk

Study published in the Journal of Internal Medicine (Wiley). Research led by Sin Gon Kim, MD, PhD, Korea University College of Medicine.

They share the same peninsula, the same ancestry, and largely the same genetic makeup. But North Korean defectors who resettle in South Korea carry a cancer profile that looks nothing like their new neighbors' -- at least not at first.

A study published in the Journal of Internal Medicine has tracked cancer incidence among 25,798 North Korean defectors using South Korea's National Health Insurance database, matching them against more than 1.27 million South Korean residents. The results paint a striking picture of how rapidly environment can rewrite cancer risk, even within a single lifetime.

Two countries, two cancer landscapes

The data revealed a clear split. Defectors arrived with higher rates of cancers tied to chronic infections -- liver cancer, linked to hepatitis B and C, and cervical cancer, driven by human papillomavirus. These are cancers more common in lower-income settings where sanitation, vaccination, and screening lag behind.

Meanwhile, their rates of breast, colon, and prostate cancer were notably lower than those of native South Koreans. These are the so-called cancers of affluence, associated with diets high in processed food, sedentary behavior, and other hallmarks of industrialized life.

That gap, however, did not hold steady. Over time, the defectors' cancer profiles began to converge with those of South Koreans. The pattern suggests that the environmental and lifestyle factors driving cancer risk are not fixed at birth or locked in by early-life exposure alone. They shift, sometimes within years, as people adopt new diets, new habits, and new levels of healthcare access.

A living laboratory for cancer epidemiology

What makes this study unusually valuable is its natural experimental design. Geneticists and epidemiologists have long debated how much of cancer risk is inherited versus acquired. Twin studies and migration studies have offered clues, but the Korean case provides something rarer: two genetically similar populations separated by radically different environments for roughly seven decades, then reunited.

North Korea's economic isolation, food scarcity, and limited healthcare infrastructure create an environment vastly different from South Korea's high-income, technology-saturated society. When defectors cross that divide, they bring their early-life exposures with them -- but then start accumulating new ones.

The researchers leveraged South Korea's universal health insurance system, which captures virtually every cancer diagnosis in the country. That level of population-wide data is difficult to replicate elsewhere and gives the findings considerable statistical weight.

Infection versus lifestyle: the epidemiological transition in miniature

The shift the researchers observed mirrors what epidemiologists call the epidemiological transition -- the pattern seen across decades in countries moving from poverty to prosperity. As nations industrialize, infectious disease rates decline while chronic diseases, including certain cancers, rise.

What normally takes a country generations to experience, defectors compress into years. Their cancer profiles essentially fast-forward through the transition, offering a compressed timeline that researchers can study in detail.

The liver cancer finding is particularly telling. Hepatitis B remains endemic in North Korea, where vaccination programs have been inconsistent. South Korea, by contrast, launched an aggressive hepatitis B vaccination campaign in the 1980s and has seen liver cancer rates decline steadily. Defectors arrive with the viral burden of their homeland but gain access to South Korean screening and treatment -- a combination that may explain some of the convergence over time.

What the data cannot tell us

The study has important boundaries worth noting. The researchers relied on health insurance records, which capture diagnoses but not the full complexity of patients' lives. Defectors face significant stressors beyond their medical histories -- psychological trauma, social isolation, economic hardship, and discrimination -- all of which can influence health outcomes in ways the database cannot fully capture.

The sample, while large at nearly 26,000 defectors, still represents a specific population: people who successfully fled North Korea and navigated the resettlement process in South Korea. They may not be representative of the broader North Korean population. Selection bias is inherent in any study of migrants, and defectors are a particularly self-selected group.

Additionally, the follow-up period, while meaningful, may not be long enough to capture the full trajectory of cancer risk adaptation. Some cancers take decades to develop, and the study may be observing only the early phase of a longer transition.

The researchers also could not fully account for differences in cancer screening behavior. South Korea has one of the most aggressive cancer screening programs in the world, which could inflate apparent cancer rates among defectors simply because more cancers are being detected, not because more are developing.

Lessons beyond the Korean peninsula

The findings carry implications well beyond the specific case of Korean reunification. Refugee populations worldwide undergo similar environmental transitions -- from conflict zones or low-income countries to high-income host nations. Understanding how their cancer risk evolves could help public health systems prepare.

For clinicians treating resettled refugees, the data suggest a dual approach: screening for infection-related cancers that reflect patients' countries of origin while monitoring for the lifestyle-related cancers that will become more relevant over time.

Sin Gon Kim, the study's corresponding author at Korea University College of Medicine, framed the work as a model for other transitional populations, noting its potential to guide prevention and health planning for vulnerable groups worldwide.

The broader takeaway is both sobering and, in a limited way, encouraging. Cancer risk is not destiny. It responds to environment, and it can change. But that plasticity cuts both ways -- the same forces that reduce infection-related cancers can, if unmanaged, drive up the cancers associated with modern life.